Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
DIH Holding US, Inc. Warrants (DHAIW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/02/2025: DHAIW (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -73.33% | Avg. Invested days 10 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/02/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.03 | 52 Weeks Range 0.01 - 0.12 | Updated Date 06/24/2025 |
52 Weeks Range 0.01 - 0.12 | Updated Date 06/24/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.79% | Operating Margin (TTM) -17.49% |
Management Effectiveness
Return on Assets (TTM) -4.63% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 15773934 |
Shares Outstanding - | Shares Floating 15773934 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
DIH Holding US, Inc. Warrants
Company Overview
History and Background
DIH Holding US, Inc., now known as Shanghai Uplus Holding Group Co., Ltd., was founded in 1998. It started as a real estate company in Shanghai and gradually expanded into the healthcare and medical rehabilitation sectors. The warrants are related to the company's earlier business structure, specifically its US-related activities.
Core Business Areas
- Real Estate Development: Historically, the company's core business was real estate development in China, focusing on residential and commercial projects.
- Healthcare and Medical Rehabilitation: More recently, DIH Holding has expanded into healthcare, including medical rehabilitation technology and services.
Leadership and Structure
The leadership structure consists of a board of directors and executive management team based in Shanghai. The organizational structure reflects a traditional hierarchical model common in Chinese companies.
Top Products and Market Share
Key Offerings
- Real Estate Projects: Residential and commercial real estate developments in Shanghai and other major Chinese cities. Market share data varies by region and project; direct figures are not readily available without extensive market research. Competitors include large Chinese developers like China Vanke and Poly Real Estate.
- Medical Rehabilitation Technology: DIH Holding provides rehabilitation equipment and software solutions. Market share data is not readily available. Key competitors include Hocoma (Switzerland) and Motek Medical (Netherlands).
Market Dynamics
Industry Overview
The real estate market in China is characterized by high demand, rapid urbanization, and government regulation. The medical rehabilitation market is growing due to an aging population and increasing prevalence of chronic diseases.
Positioning
DIH Holding aims to establish a significant presence in both the real estate and healthcare sectors in China. Its competitive advantage lies in its local market knowledge and government relationships.
Total Addressable Market (TAM)
The TAM for real estate in China is estimated to be in the trillions of USD, and the TAM for medical rehabilitation is estimated to be in the billions of USD. DIH Holding is positioned to capture a share of these large markets through its local operations.
Upturn SWOT Analysis
Strengths
- Strong presence in the Chinese market
- Diversified business portfolio (real estate and healthcare)
- Established government relationships
- Local market expertise
Weaknesses
- Exposure to the volatility of the Chinese real estate market
- Limited international brand recognition (especially in healthcare)
- Complex ownership structure
- Information transparency concerns
Opportunities
- Expanding healthcare services to meet growing demand
- Leveraging technology to enhance real estate development
- Acquiring international healthcare companies to expand global reach
- Increasing investment in R&D for medical rehabilitation technology
Threats
- Increased government regulation of the real estate market
- Competition from larger and more established healthcare companies
- Economic slowdown in China
- Geopolitical risks
Competitors and Market Share
Key Competitors
- CGREF
- HOCNF
- OTCQX:LKYSF
Competitive Landscape
DIH Holding faces strong competition in both real estate and healthcare. Its advantages include local market knowledge and government relationships. Its disadvantages include lower brand recognition compared to some global competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is tied to the performance of DIH Holding's core businesses (real estate and healthcare).
Future Projections: Future projections are dependent on the growth of the Chinese economy, the real estate market, and the healthcare sector. Analyst estimates are not readily available for warrants specifically, but they exist for Shanghai Uplus Holding Group.
Recent Initiatives: Recent initiatives include expansion of healthcare services, investment in medical rehabilitation technology, and ongoing real estate development projects.
Summary
DIH Holding US, Inc. Warrants are speculative investments linked to DIH Holding (Shanghai Uplus Holding Group Co., Ltd.). DIH Holding operates in the Chinese real estate and healthcare sectors. While DIH benefits from its local market knowledge and government relationships, it faces competition in both sectors and exposure to the Chinese economy. Potential investors should carefully evaluate the risks associated with investing in warrants tied to a Chinese company.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Market Research Reports
- Financial News Articles
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with a financial advisor before making any investment decisions. Market share data are estimates and should be treated with caution.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DIH Holding US, Inc. Warrants
Exchange NASDAQ | Headquaters Norwell, MA, United States | ||
IPO Launch date 2022-03-21 | Founder, Chairman & CEO Mr. Jason Chen | ||
Sector Healthcare | Industry Medical Devices | Full time employees - | Website https://www.dih.com |
Full time employees - | Website https://www.dih.com | ||
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.